Crypto Co — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Crypto Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $207.9K | Jun 13, 2025 |
| FY2017 | Dec 31, 2017 | $787.4K | Apr 2, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $44.8K | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | $10.3K | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | $9.8K | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | $15.8K | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | $197.5K | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | $122.0K | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | $28.6K | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | $29.1K | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | $619.5K | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | $434.6K | Apr 17, 2023 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $0 | Mar 10, 2017 |
| FY2016 | Dec 31, 2015 | $308 | Mar 10, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $35.4K | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | $2.9K | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | $2.1K | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | $14.3K | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | ($116.3K) | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | $107.1K | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | ($88.7K) | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | ($68.8K) | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | $250.2K | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | $160.8K | Apr 17, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($6.64M) | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | ($3.13M) | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | ($874.4K) | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | ($1.09M) | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | ($7.23M) | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | ($361.0K) | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | ($860.5K) | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | ($2.90M) | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | ($5.66M) | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | ($785.6K) | Apr 17, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($6.14M) | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | ($3.06M) | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | ($681.2K) | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | ($891.7K) | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | ($4.13M) | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | ($261.7K) | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | ($539.9K) | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | ($897.2K) | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | ($3.85M) | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | ($2.08M) | Apr 17, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $0 | Mar 10, 2017 |
| FY2016 | Dec 31, 2015 | $2.5K | Mar 10, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($813.5K) | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | ($1.64M) | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | ($1.93M) | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | ($152.2K) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($302.8K) | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | ($1.16M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($6.27M) | May 19, 2020 |
| FY2018 | Dec 31, 2017 | ($3.13M) | Jul 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2018 | $42.7K | May 19, 2020 |
| FY2018 | Dec 31, 2017 | $73.0K | Jul 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.8K | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | $9.7K | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | $43.5K | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | $43.1K | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | $73.0K | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | $1.31M | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | $1.33M | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | $1.38M | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | $1.56M | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | $1.52M | Apr 17, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.70M | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | $6.26M | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | $6.15M | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | $5.73M | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | $6.34M | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | $5.42M | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | $5.34M | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | $5.15M | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | $4.62M | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | $2.54M | Apr 17, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($6.70M) | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | ($6.25M) | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | ($6.10M) | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | ($5.69M) | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | ($6.26M) | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | ($4.11M) | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | ($4.01M) | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | ($3.77M) | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | ($3.06M) | Jul 30, 2025 |
| FY2023 | Dec 31, 2021 | ($1.02M) | Jul 30, 2025 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $740.5K | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | $740.5K | Apr 16, 2024 |
| FY2023 | Sep 30, 2023 | $740.5K | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | $740.5K | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | $740.5K | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | $740.5K | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | $740.5K | Apr 17, 2023 |
| FY2019 | Dec 31, 2018 | $1.69M | May 19, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($53.41M) | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | ($52.24M) | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | ($48.70M) | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | ($47.02M) | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | ($46.76M) | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | ($43.66M) | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | ($43.30M) | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | ($42.43M) | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | ($39.53M) | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | ($33.87M) | Apr 17, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.8K | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | $6.7K | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | $31.4K | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | $21.9K | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | $73.0K | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | $20.4K | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | $17.7K | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | $16.7K | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | $110.6K | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | $75.7K | Apr 17, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | 0 | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | 0 | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | 0 | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | 0 | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Jul 30, 2025 |
| FY2017 | Dec 31, 2017 | 0 | Apr 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 13, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Jun 13, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Jun 13, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | 0 | Jul 30, 2025 |
| FY2023 | Sep 30, 2023 | 0 | Jul 30, 2025 |
| FY2023 | Jun 30, 2023 | 0 | Jul 30, 2025 |
| FY2023 | Mar 31, 2023 | 0 | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Jul 30, 2025 |
| FY2017 | Dec 31, 2017 | 0 | Apr 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 3.03B | Jun 13, 2025 |
| FY2023 | Dec 31, 2023 | 565.71M | Jul 30, 2025 |
| FY2023 | Dec 31, 2022 | 23.95M | Jul 30, 2025 |
| FY2022 | Dec 31, 2021 | 22.21M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 21.42M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | 21.40M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | 20.46M | May 19, 2020 |
| FY2018 | Dec 31, 2017 | 20.46M | Jul 26, 2019 |
| FY2016 | Dec 31, 2016 | 11.12M | Mar 10, 2017 |
| FY2016 | Dec 31, 2015 | 10.00M | Mar 10, 2017 |